He and his team have also proposed a relationship between IL-33 and diseases such as sepsis (38), oncological chemotherapy (39), Alzheimer’s disease (40), and cerebral malaria (41, 42), and suggest that IL-33 is a double-edged sword, the rational regulation of which may have considerable potential therapeutic effects. This evidence concerns the gene IL33 and Alzheimer disease.